Is Topical Dutasteride The Holy Grail? - AS GOOD As Oral Dutasteride WITHOUT The Side Effects!?

More Plates More Dates
29 Dec 202029:46

Summary

TLDRThe video discusses topical dutasteride as a treatment for hair loss, comparing it to oral administration and exploring its potential benefits and drawbacks. It delves into the pharmacological effects of dutasteride, the impact of metabolites, and the possibility of localized scalp DHT inhibition without systemic side effects. The speaker shares anecdotal evidence and personal insights, suggesting that topical dutasteride could be a promising alternative for those seeking hair loss solutions with fewer side effects.

Takeaways

  • 🧪 Topical dutasteride is being explored as a method to achieve localized 5-alpha reductase (5AR) inhibition with minimal systemic absorption, which is a novel approach in hair loss treatments.
  • 💊 The molecular weight difference between finasteride and dutasteride may affect their topical application efficacy, with dutasteride's higher molecular weight possibly allowing for more targeted scalp treatment.
  • 📉 Topical dutasteride might offer a more favorable reduction in scalp DHT levels compared to serum DHT levels, which is a desirable outcome for treating hair loss.
  • 🚫 Oral dutasteride has more side effects than topical or mesotherapy applications, suggesting that topical administration could be a safer alternative.
  • 🔬 Clinical studies show oral dutasteride outperforms mesotherapy and topical dutasteride, but the side effects and systemic absorption are significant considerations.
  • 🌡️ The first-pass metabolism of oral medications creates metabolites that may have their own 5AR inhibiting properties, which are bypassed when using topical applications.
  • ✂️ Topical administration allows for greater dosage manipulation, offering the potential for microdosing and tailored treatments.
  • 🧬 Dutasteride's metabolites, such as 6-hydroxy dutasteride and 4-hydroxy dutasteride, have their own pharmacological effects, which may influence the overall treatment outcome.
  • 📈 Topical dutasteride could potentially lead to quicker returns to baseline DHT levels compared to oral administration, which may be beneficial for managing side effects.
  • 🤔 There is a need for more research and data on the long-term effects and efficacy of topical dutasteride, as current evidence is largely anecdotal.
  • 🛑 The script suggests that a comprehensive hair loss treatment protocol might involve a combination of topical dutasteride and anti-androgens to address both DHT reduction and androgen receptor activation.

Q & A

  • What is the main topic of discussion in the provided script?

    -The main topic of discussion is topical dutasterides, specifically its potential as a treatment for hair loss and the various aspects related to its use, including different administration techniques, molecular weight considerations, and its effects compared to oral administration.

  • What are the different administration techniques for dutasteride mentioned in the script?

    -The script mentions several administration techniques for dutasteride, including topical solutions, liposomal formulations, and mesotherapy, which is an intradermal injection of dutasteride into the scalp.

  • What is the goal of using dutasteride in a topical format or mesotherapy?

    -The goal is to achieve a high level of localized 5-alpha reductase (5AR) inhibition with a relative lack of systemic absorption, potentially offering a more targeted approach to hair loss treatment.

  • What is the difference between the molecular weight of finasteride and dutasteride, and why is it significant for topical application?

    -Finasteride has a molecular weight under 400 daltons, while dutasteride is around 500 daltons, which influences its ability to penetrate the skin effectively for topical use.

Outlines

00:00

🧪 Topical Dutasteride: A Novel Approach to Hair Loss Treatment

The speaker explores the concept of topical dutasteride as an alternative to oral administration for hair loss treatment. They discuss various methods of administration, including liposomal formulations and mesotherapy, highlighting the goal of achieving high localized 5-alpha reductase (5AR) inhibition with minimal systemic absorption. The speaker also compares the molecular weights of finasteride and dutasteride, suggesting that dutasteride's weight over 500 daltons might make it a more viable topical treatment. They delve into the pharmacological effects of dutasteride and its metabolites, emphasizing the potential benefits of topical application in avoiding first-pass metabolism and systemic side effects.

05:02

📊 Topical vs. Oral Administration: Metabolites and Their Impact

This paragraph delves into the differences between topical and oral administration of dutasteride, focusing on the impact of first-pass metabolism and the production of metabolites. The speaker explains how topical application can lead to a disproportionate increase in the parent compound compared to its metabolites, which might contribute to the drug's efficacy and reduced side effects. They discuss the potential for a quicker return to baseline DHT levels with topical application and speculate on the effects of various metabolites, such as 6-hydroxy dutasteride and 2-hydroxy dutasteride, on the pharmacological profile of the treatment.

10:03

🔬 Dutasteride's Molecular Weight and Topical Application Theories

The speaker discusses the theory behind dutasteride's molecular weight and its potential effectiveness as a topical treatment. They suggest that dutasteride's molecular weight being just over 500 daltons might allow for some penetration into the scalp, but not enough to cause systemic issues. The paragraph also touches on the importance of the vehicle used in topical formulations to manipulate penetration and achieve the desired local effect. The speaker shares anecdotal evidence and blood work observations that indicate promising results for topical dutasteride, including reduced scalp DHT levels with minimal systemic impact.

15:04

💊 Dosage Manipulation and Topical Dutasteride's Advantages

The speaker compares the flexibility of dosage manipulation between finasteride and dutasteride, highlighting the limitations of dutasteride's soft gel capsule form. They argue that topical dutasteride offers more control over dosage and frequency of application, which could be beneficial for individuals who are risk-averse or concerned about side effects. The paragraph also discusses the potential for a more rapid return to normal DHT levels with topical application, as opposed to the longer-lasting effects of oral dutasteride.

20:04

🤔 Exploring Topical Dutasteride: Risks, Benefits, and Individual Considerations

In this paragraph, the speaker reflects on the potential of topical dutasteride, considering its risks and benefits. They suggest that it may be a viable option for those who are prone to side effects from other treatments or who are seeking a less aggressive approach to DHT inhibition. The speaker also raises questions about the long-term effects of topical application on neural steroid production and the need for further research to understand the full implications of this treatment method.

25:04

🧩 Broadening the Treatment Perspective: Beyond DHT Inhibition

The speaker expands the discussion to consider the broader implications of inhibiting DHT, particularly the potential for increased scalp testosterone levels. They suggest that a comprehensive treatment protocol might involve the use of anti-androgens or selective androgen receptor modulators to address the complex interplay of androgens in the body. The paragraph concludes with a call for a holistic approach to hair loss treatment, considering the entire steroidogenesis cascade and the potential need for additional interventions such as microneedling or minoxidil.

📈 Conclusion: The Promise of Topical Dutasteride and Future Directions

The speaker concludes by summarizing the potential of topical dutasteride and suggesting it as a promising avenue for further exploration. They acknowledge the need for more data and research but express optimism based on anecdotal evidence and personal observations. The speaker also mentions their interest in potentially working with a compounding pharmacy to make topical dutasteride more widely available. They end with a reminder of the importance of a comprehensive approach to hair loss treatment and a plug for their associated products and services.

Mindmap

Keywords

💡Dutasteride

Dutasteride is a medication used to treat hair loss in men, specifically by inhibiting the conversion of testosterone to dihydrotestosterone (DHT), a hormone linked to male pattern baldness. In the video, it is discussed in various forms, including oral and topical applications, with a focus on its potential benefits and side effects compared to other treatments like finasteride.

💡Topical Dutasteride

Topical Dutasteride refers to a form of the medication applied directly to the scalp, as opposed to being taken orally. The script discusses the potential advantages of topical application, such as localized 5-alpha reductase (5AR) inhibition with minimal systemic absorption, and the possibility of achieving high levels of scalp DHT reduction without the side effects associated with oral intake.

💡5-alpha reductase (5AR) inhibition

5AR inhibition is the process of blocking the enzyme 5-alpha reductase, which converts testosterone to DHT. The video discusses the importance of 5AR inhibition in treating hair loss and the different methods of achieving this, including oral and topical administration of dutasteride.

💡Systemic absorption

Systemic absorption refers to the process by which a substance is absorbed into the bloodstream and distributed throughout the body. The script contrasts the systemic absorption of oral dutasteride, which can lead to side effects, with the more localized effects of topical application, which may reduce systemic exposure and side effects.

💡Mesotherapy

Mesotherapy is a method mentioned in the script where dutasteride is injected directly into the scalp tissue. This technique is used to achieve a high level of localized 5AR inhibition, and it is part of the broader discussion on innovative treatments for hair loss.

💡Pharmacokinetics

Pharmacokinetics is the study of how a drug moves through the body, including its absorption, distribution, metabolism, and excretion. The script discusses the pharmacokinetics of dutasteride, particularly the impact of topical application on the levels of the drug and its metabolites in the body.

💡First-pass metabolism

First-pass metabolism is the initial breakdown of a drug that occurs as it passes through the liver after oral administration. The script explains that topical application of dutasteride allows for a higher concentration of the parent compound to reach the scalp, bypassing first-pass metabolism and its associated production of metabolites.

💡Metabolites

Metabolites are the substances produced when a drug is broken down in the body. The script discusses specific metabolites of dutasteride, such as 6-hydroxy dutasteride and 4-hydroxy dutasteride, and how their production and effects differ based on whether the drug is taken orally or applied topically.

💡Molecular weight

Molecular weight is the mass of a molecule, and it can affect a substance's ability to penetrate the skin when applied topically. The script notes that dutasteride's molecular weight is over 500 daltons, which is considered a threshold that may limit its penetration and systemic absorption when applied topically, potentially enhancing its efficacy as a topical treatment.

💡Microdosing

Microdosing refers to the practice of taking a very small dose of a substance, often a drug, to achieve a specific effect without experiencing full-blown effects. The script suggests that the topical application of dutasteride could allow for microdosing to potentially achieve hair loss prevention with minimal systemic inhibition of DHT.

💡Androgen receptor activation

Androgen receptor activation is the process by which androgen hormones, like testosterone and DHT, bind to androgen receptors to exert their effects in the body. The script discusses the broader implications of reducing scalp DHT levels, such as the potential for increased scalp testosterone levels and the need for other treatments to manage androgen receptor activation.

Highlights

Topical dutasteride is being explored as a potential treatment for hair loss with less systemic absorption than oral forms.

Different administration techniques for topical dutasteride include solutions, liposomal formulations, and mesotherapy injections directly into the scalp.

The goal of topical 5α-reductase inhibitors is to achieve high localized 5α-reductase (5AR) inhibition with minimal systemic absorption.

Oral dutasteride has been shown to outperform mesotherapy and topical dutasteride in clinical studies, but with more side effects.

The molecular weight of dutasteride (over 500 daltons) may make it a more viable topical therapy compared to finasteride.

Topical application of dutasteride might allow for more precise control over dosage and frequency compared to oral administration.

Dutasteride metabolites, such as 6-hydroxy dutasteride and 4-hydroxy dutasteride, have their own 5AR inhibiting properties and contribute to the drug's effects.

Topical dutasteride might offer a more favorable scalp to serum DHT reduction ratio compared to finasteride.

Some users report a quicker return to baseline DHT levels with topical dutasteride than with oral forms.

Topical dutasteride could potentially have less side effects due to reduced systemic exposure to metabolites.

The speaker suggests that topical dutasteride may be a promising option for those who are risk-averse or concerned about side effects.

Dutasteride's half-life and the half-lives of its metabolites are important factors to consider when evaluating the drug's effects over time.

The speaker discusses the potential for a disproportionate decrease in scalp DHT with topical dutasteride, possibly leading to increased scalp testosterone.

Topical dutasteride might be a good preliminary treatment for those considering oral dutasteride to assess tolerability.

The speaker mentions the possibility of using compounding pharmacies to create lower dosage tablets of dutasteride.

The transcript explores the broader implications of scalp DHT reduction, including the need for strategies to manage increased scalp testosterone.

The speaker concludes that while more data is needed, topical dutasteride shows promise and is worth exploring for hair loss treatment.

Transcripts

play00:00

so the same thing with dutaster is going

play00:01

to apply you're going to have

play00:03

when you apply it to your head you're

play00:04

going to get less

play00:06

of a disproportionate rise in this six

play00:09

hydroxy dutas right four hydroxy

play00:10

dutasteride one two dihydro dutasteride

play00:13

is that a good or bad thing though are

play00:15

those the things that are

play00:16

literally responsible for the majority

play00:18

of the long-term pharmacologic effects

play00:20

you know i think this sort of reinforces

play00:23

why

play00:24

the topic will do tasks right

play00:36

what's up guys derek for

play00:37

playsmartdates.com today we're going to

play00:38

be talking about

play00:40

topical dutasterides so you know there's

play00:42

different

play00:43

administration techniques even among

play00:46

topical dutasteride

play00:47

intervention in general there is um just

play00:50

straight up

play00:51

topical solutions there are liposomal

play00:54

formulations there are

play00:56

something called mesotherapy where it's

play00:58

literally um

play00:59

an intradermal injection of dutasteride

play01:02

into the scalp itself to achieve

play01:04

well the goal of it is to achieve um

play01:07

like a high level of localized 5ar

play01:09

inhibition with a relative lack of

play01:11

systemic absorption

play01:12

and this is one of the most uh you know

play01:15

forward thinking

play01:16

of the i don't know treatments involving

play01:18

5ar inhibition

play01:20

and it's uh picking up a lot of steam

play01:22

lately or at least in the niche

play01:24

niche community that researches this

play01:26

[ __ ] it's picking up steam i guess

play01:28

um so anyways due task right has been

play01:30

looked at in a lot of ways and obviously

play01:31

orally as well

play01:32

so i kind of want to just give my stance

play01:34

on it from what i've seen

play01:36

over the past couple years of looking

play01:38

into this um

play01:39

anecdotal findings reports from people

play01:42

in the community that i'm friends with

play01:44

or

play01:44

other anecdotes from random people who

play01:46

follow my stuff you send me messages

play01:48

i've received just like hordes of [ __ ]

play01:50

over the past

play01:51

years of hair loss stuff now for do task

play01:55

right in particular

play01:56

not a lot of people use it topically it

play01:58

is sort of a

play01:59

new um relatively uncharted waters i

play02:04

guess

play02:05

reason being is oral works very well so

play02:07

most people are going to just use oral

play02:08

and if you actually look at the clinical

play02:10

studies comparing oral versus topical

play02:12

or even mesotherapy oral dutasteride

play02:15

outperforms mesotherapy and topical

play02:17

dutasteride however this does not come

play02:19

with

play02:20

without downside obviously because there

play02:22

is more side effects

play02:24

found in the oral groups now this is

play02:26

different

play02:27

than the if you could see the topical

play02:29

finasteride versus the oral finasteride

play02:31

studies you find that

play02:33

any kind of like disproportionate

play02:34

advantage it seems to have seems to

play02:36

essentially

play02:37

disintegrate upon reaching steady state

play02:40

concentrations in the body it goes

play02:41

systemic just the same

play02:43

and seems to pretty much do the exact

play02:45

same [ __ ] as far as systemic versus

play02:47

scalp dht inhibition

play02:48

however the molecular weight of

play02:50

finasteride versus dutasteride is

play02:52

different this is sort of where

play02:54

it gets a bit bro-sciency but also is

play02:56

like part of the

play02:57

theory behind dutasteride topically

play02:59

being potentially a more

play03:01

viable therapy in a topical format

play03:04

versus oral of finasteride versus two

play03:07

tasks right finasteride has a

play03:08

molecular weight under um 400 daltons

play03:12

and dutasteride is like 528 daltons or

play03:15

something like that

play03:16

so you know the classic rule is that if

play03:19

it's under 500

play03:21

daltons then you can apply it in a

play03:23

topical solution and get it into

play03:25

the scalp to do what it's supposed to do

play03:27

locally and if the molecular mass

play03:29

is over 500 daltons then you know it's

play03:32

thought

play03:33

that it's not going to be able to um

play03:35

penetrate and

play03:36

you know yield a pharmacological effect

play03:38

whatsoever

play03:39

which sort of actually is part of the uh

play03:43

theory around dutaster that sort of

play03:45

reinforces its efficacy as a topical

play03:47

solution

play03:48

is its molecular weight being over 500

play03:50

daltons so they think well some people

play03:51

speculate it's not like anyone actually

play03:53

knows

play03:54

um that it's sort of like

play03:57

um gets like sort of in there but like

play04:00

not enough that it gets like deep enough

play04:02

to be problematic but it's

play04:03

enough to produce the pharmacologic

play04:05

effect we're seeking because it's like

play04:06

right on the brink of 500

play04:08

and we can sort of manipulate the

play04:09

penetration

play04:11

with different vehicles to kind of

play04:12

achieve getting right where we want it

play04:14

to without getting like

play04:16

two in there which you know like what is

play04:18

the likelihood of us actually being able

play04:20

to do that

play04:20

you know it's [ __ ] tough to speculate

play04:23

about but

play04:24

some of the blood work does sort of

play04:26

reinforce um

play04:29

it as a potentially viable solution for

play04:31

a lot of people in my opinion i'm gonna

play04:32

sort of get into my reason why

play04:34

after but i'm sort of just like checking

play04:36

off all the boxes in terms of all the

play04:38

points

play04:39

that are like commonly brought up when

play04:40

it comes to dutasteride versus

play04:42

finasteride

play04:43

the efficacy of topical solutions and

play04:45

blah blah blah so finasteride like i

play04:47

said we see a pretty much

play04:48

equivalent scalp and serum dht reduction

play04:51

now does that mean that topical

play04:53

finasteride has no merit

play04:55

and that it should not be opted for

play04:57

instead of oral like not necessarily

play04:59

because there is like we've seen even

play05:01

with uh topical testosterone

play05:04

applications when you apply it scrotally

play05:06

you know you can get a disproportionate

play05:08

spike in dht concentrations just by the

play05:11

local

play05:11

5ar activity of the application site so

play05:14

why could we not leverage the exact same

play05:17

mechanism via your scalp you know

play05:19

theoretically if you can

play05:20

disproportionately increase dht

play05:22

relative to your t dose by applying it

play05:25

under your nut sac

play05:26

why can you not get a disproportionate

play05:29

decrease in dht by applying

play05:31

a 5ar inhibitor to your scalp right at

play05:34

the other place where there is a

play05:35

disproportionately high amount of

play05:37

5ar you know you would think that sort

play05:39

of makes sense in practical application

play05:40

with the topical finasteride we don't

play05:42

really see that play out in the blood

play05:44

work or the scalp biopsies though

play05:46

however with dutasteride maybe it's a

play05:48

bit different and something to note as

play05:49

well

play05:50

is first pass metabolism when you apply

play05:52

something topically

play05:54

you skip first pass and the oral

play05:57

bioavailability

play05:58

of finasteride and due task right is not

play06:00

100 it is if i recall correctly

play06:02

somewhere around

play06:03

somewhere around 60 to 65 i believe

play06:05

finasteride is

play06:06

65 due taster it's like 60 or something

play06:09

like that so anyways

play06:10

when it goes through metabolism and

play06:13

uh gets metabolized by the liver there

play06:16

is

play06:17

metabolites that are produced when you

play06:18

take finasteride you take deutastroid

play06:20

and especially with do taste right these

play06:22

produce unique

play06:24

and um unique metabolites with their own

play06:28

inherent 5ar inhibiting properties so

play06:30

part of the pharmacological effect of

play06:32

deutastrite

play06:33

is provided not just by the parent

play06:36

compound itself but perhaps by its

play06:38

metabolites during first pass metabolism

play06:40

so

play06:40

when you apply something topically you

play06:42

skip first pass you get a

play06:44

disproportionate

play06:45

increase in the parent compound as well

play06:47

relative

play06:48

to the metabolite so you're actually

play06:50

getting less

play06:51

of the um what are the metabolites i'm

play06:54

going to pull up the

play06:55

wikipedia thing right now so i can

play06:56

remember them um

play07:01

do test right let's see

play07:05

pharmacokinetics

play07:08

um okay so for six hydroxy dutas right

play07:12

four hydroxy dutas right and one two

play07:14

dihydrotasteride so

play07:16

these are uh the three major metabolites

play07:19

um that form via um first pass

play07:23

so it's almost like you know when you

play07:25

look at oral estradiol versus

play07:26

transdermal versus iv versus sublingual

play07:29

there's a reason you see a

play07:30

disproportionate spike in estrone

play07:32

relative to estrogen levels

play07:33

when you take oral estradiol when you

play07:36

take it sublingually or apply it

play07:38

transdermally or inject it though

play07:39

you have a more physiologic

play07:41

representation of a balance between

play07:42

normal amounts of estrogen

play07:44

relative to estrone because you are

play07:46

skipping that first pass metabolism so

play07:48

the same thing with dutaster is going to

play07:50

apply you're going to have

play07:51

when you apply it to your head you're

play07:53

going to get less

play07:54

of a disproportionate rise in this six

play07:57

hydroxy do test right four hydroxy dutas

play07:59

right one two dihydrodutastride

play08:01

is that a good or bad thing though are

play08:03

those the things that are

play08:05

literally responsible for the majority

play08:07

of the long-term pharmacologic effects

play08:09

you know i think this sort of reinforces

play08:12

why

play08:13

the topical due tasterite may have a lot

play08:16

of promise because if you're skipping

play08:18

this production of these metabolites to

play08:20

a significant extent you have to keep in

play08:22

mind they have their own inherent

play08:24

half-lives they have their own inherent

play08:26

um ability to bind to favor

play08:28

5ar with a certain affinity a certain

play08:30

binding constant a certain dissociation

play08:32

rate there's these things

play08:33

that are associated with all these

play08:34

compounds this is an entirely new thing

play08:36

that you're looking at for each

play08:38

metabolite it's not just what is the

play08:39

dutasteride doing

play08:40

it's also what's happening with all this

play08:42

[ __ ] like this is why um

play08:44

even with oral steroids like half the

play08:46

time

play08:47

like the [ __ ] that you're taking it's

play08:48

not even necessarily

play08:50

the parent compound yielding the effect

play08:52

that you're getting and you're trying to

play08:53

get out of it like sometimes

play08:55

you know with anadrol i speculate that

play08:57

the standalone conversion in the liver

play08:58

might be like

play09:00

a lot of the adrenergic signaling you

play09:01

get out of a pre-workout like maybe

play09:03

that's why it even works to begin with

play09:05

maybe the parent compound

play09:06

[ __ ] sucks as a pre-workout you know

play09:08

there's a lot of things that come via

play09:09

that metabolism process that you're

play09:11

losing out on

play09:12

or winning out on potentially when you

play09:14

use it in a different format of

play09:16

administration

play09:17

so with dutastride in particular the

play09:19

thing that interests me

play09:21

is that when i see blood work before and

play09:22

after i see

play09:24

return to baseline a lot quicker than i

play09:27

do with oral

play09:28

which is interesting but as well it's

play09:30

also guys who are not letting it

play09:32

reach steady state they're not using it

play09:34

consistently on a day-to-day basis

play09:36

they're using it like once a week so

play09:37

you know that might play into it i

play09:39

speculate that maybe it might play into

play09:41

the

play09:42

relative lack of these major metabolites

play09:44

that are being produced during first

play09:46

pass and maybe

play09:47

it's yielding in a more i don't know a

play09:50

more uh

play09:51

not elastic but like i don't even know

play09:53

what the word is like a shorter overall

play09:55

drug burden slash half-life overall

play09:58

because you're not dealing with also

play09:59

metabolizing

play10:01

to as much of a degree these other

play10:03

metabolites which are also

play10:05

very potent five ar inhibitors like

play10:06

let's see uh d6 di hydroxy detached

play10:09

right has a similar potency

play10:10

as a 5ar inhibitor 2 dutasteride so you

play10:13

know if you're dealing with the

play10:14

half-life of deutaceride

play10:16

and then you have to deal with six

play10:17

hydroxy dutasteride two after because of

play10:19

oral

play10:20

you know that's like a whole new you

play10:21

know layer of metabolization that has to

play10:24

be worked out of your system before you

play10:25

can then return to

play10:27

normal dht levels so theoretically by

play10:29

applying it topically we might be able

play10:30

to get back to baseline

play10:32

quicker and potentially have a more

play10:36

i don't know the body might be more

play10:37

resilient to side effects because you're

play10:39

not dealing with like

play10:41

unknown amounts of metabolites at the

play10:42

same time that are also

play10:44

producing pharmacologic effects in

play10:46

satellite you know satellite

play10:48

interactions and [ __ ] that you can't

play10:49

even predict

play10:50

so you know maybe you're making the drug

play10:52

more

play10:53

manageable and gain gaining more

play10:56

leverage over the compound in terms of

play10:58

how you can manipulate it manually when

play11:00

you're using it topically too

play11:01

because you're not getting this

play11:02

disproportionate spike in the

play11:03

metabolites

play11:04

you're dealing with mainly the parent

play11:06

compound at this point so that's where i

play11:08

think it has a lot of promise

play11:09

topically as well and it sort of seems

play11:11

to be reflected in the blood work like i

play11:12

said like going back to it a little bit

play11:14

i see returns of serum dht levels

play11:18

quicker than i do with oral just on the

play11:22

minor amounts of blood work i've seen

play11:24

that's what i'm seeing in addition

play11:26

as far as how it is affecting scalp dht

play11:29

levels versus

play11:30

serum dht levels it seems to be more

play11:33

favorable

play11:34

than that of finasteride now i don't

play11:35

know if that's actually the case or if

play11:37

it's just a result of

play11:39

you know like with minoxidil like some i

play11:41

was speculating before that maybe

play11:43

minoxidil

play11:44

you might be able to yield the exact

play11:46

same effect as topical minoxidil just by

play11:48

taking like a micro dose orally that

play11:49

would otherwise yield the exact same

play11:51

side effect profile but then again

play11:53

it circles back to the thing of

play11:55

intra-tissue specific concentrations of

play11:57

compounds definitely yield a localized

play11:59

effect

play12:00

like with the scrotal testosterone and

play12:02

you know reverse engineering that on

play12:03

your scalp

play12:04

so you know a lot of times like the

play12:06

theories in my head

play12:08

i'm sort of like going to [ __ ] ramble

play12:11

and uh i'm trying to like circle back to

play12:13

my point and make it a cohesive [ __ ]

play12:15

summary here but basically

play12:16

i've had a handful of people reach out

play12:18

to me with before and after blood work

play12:20

the blood work looks solid in that when

play12:22

you take oral due to asteroids what

play12:23

happens is you

play12:24

nuke your dht levels like you get

play12:27

systemic

play12:28

inhibition of 5ar to a point where you

play12:31

are literally

play12:33

like a prepubescent child after you use

play12:35

it with topical dutastra i've seen

play12:37

people use

play12:38

upwards of like double digit milligrams

play12:41

on their head

play12:42

which would otherwise be an amount

play12:44

orally

play12:46

which would nuke your dht now obviously

play12:49

topically you're not gonna get the same

play12:50

absorption as you would orally you know

play12:52

just like with minoxidil you're using

play12:53

like five percent solution you're using

play12:55

50 milligrams on your head

play12:57

if you took orally 50 milligrams you get

play12:59

[ __ ] destructed

play13:00

with due to asteroid though if you took

play13:02

you know in the double digits

play13:04

um you would expect like a significant

play13:06

reduction in dht

play13:08

like serum not not just your scalp but

play13:10

what we do see is a disproportionate

play13:12

decrease in the scalp

play13:14

dht and the lesser of a decrease

play13:16

systemically

play13:17

now is that just a lag effect or

play13:21

is that actual like intra-tissue

play13:24

localized effects going on that we're

play13:26

actually trying to seek and sort of like

play13:27

actually capitalizing

play13:29

on the reverse engineering the scrotal

play13:31

testosterone thing and actually having

play13:32

it work up here

play13:33

um i don't know for sure but what i do

play13:36

see in the blood work seems good you

play13:38

know it's guys who are getting uh

play13:39

you know like 60 to 70 to 80 percent

play13:42

scalp dhd inhibition

play13:43

with 20 to 40 percent of serum dhc

play13:46

inhibition

play13:47

using dosages that you would otherwise

play13:49

think would go systemic and [ __ ] them up

play13:52

and it just doesn't seem to be the case

play13:53

and these are guys that are used to get

play13:55

side effects from using

play13:56

even topical finasteride and then they

play13:58

take topical dutasteride

play14:00

and paradoxically they don't experience

play14:02

side effects so

play14:03

it's just really interesting to me you

play14:05

know maybe the molecular weight plays

play14:07

some role in it

play14:08

maybe it has to do with the uh

play14:10

application

play14:11

frequency and the half-life and the

play14:13

relative lack of metabolite production

play14:14

because with finasteride

play14:16

like all of these compounds are their

play14:17

own compounds too like when finasteride

play14:19

is metabolized and it goes through the

play14:21

liver

play14:21

it makes its own metabolites too so as

play14:23

far as like the inherent 5ar inhibition

play14:25

potential of all the finasteride

play14:27

metabolites due tasterite metabolites

play14:29

the half-lives of those compounds how

play14:30

they affect other satellite interactions

play14:32

in the body

play14:33

how they affect other enzymes and other

play14:35

physiologic processes that are going on

play14:37

at the same time

play14:37

you know you can't predict any of this

play14:39

[ __ ] we only know what's going on with

play14:40

the parent compounds and we barely even

play14:42

[ __ ] know that

play14:44

like that's that's how much we're

play14:45

[ __ ] extrapolating here as we're

play14:47

trying to predict with relative accuracy

play14:49

what's going on with a parent compound

play14:51

with a novel administration technique

play14:53

and then predict downstream what's going

play14:55

to happen with all of the cascades of

play14:57

metabolite

play14:57

compounds that are being produced and

play14:59

what they're going to do and what their

play15:00

half-lives are and what their inherent

play15:02

potential is to do blah blah blah

play15:03

so again we can just go off a [ __ ]

play15:06

anecdote essentially and whatever

play15:07

studies we have available

play15:09

and in the studies available they're not

play15:10

too useful to be honest

play15:12

and in the anecdotes available they're

play15:14

very limited to be honest however it

play15:16

does look promising and i think it has

play15:18

not only in all of the things i

play15:20

mentioned but also in the ability to

play15:22

manipulate your dosage

play15:24

with suit with dutasteride you don't

play15:25

have the advantage of finasteride where

play15:27

it's

play15:28

a pressed tablet at least with

play15:30

finasteride you can [ __ ]

play15:33

break it up into pieces you can

play15:35

literally crush it into dust you can

play15:37

literally

play15:38

do whatever the [ __ ] you want to it and

play15:40

make it into a micro dose if you wanted

play15:41

to

play15:42

actually titrate up and be you know

play15:45

risk-averse and kind of like

play15:47

get the you know greatest effect with

play15:49

the lowest dose and

play15:50

if you look into the finasteride data

play15:52

you can see you can get a significant

play15:53

amount of dht inhibition with a dose way

play15:55

lower than the one milligram pressed

play15:57

tablet

play15:57

you get as a propecia tablet with

play15:59

dutasteride though you're given a 0.5

play16:02

a 0.5 milligram soft gel what the [ __ ]

play16:05

do you do with that you have no choice

play16:06

but to pop the 0.5 milligram soft gel

play16:09

unless you come up with some real

play16:10

creative [ __ ] most people are popping

play16:12

the 0.5 milligram soft gel

play16:14

and getting full nuke dht serum

play16:17

scalp everything you know you have no

play16:20

manipulation of your dosage

play16:21

where and it's not like it comes in a

play16:23

format that's different like with

play16:24

finasteride

play16:25

there's a lot of manipulation you can do

play16:27

you know you can even

play16:29

opt for um well this is probably a new

play16:32

thing that's gonna be coming up but you

play16:34

know

play16:34

opting for compounding pharmacies to

play16:36

make lower dosage

play16:38

um pressed tablets you know going for

play16:40

you know a 0.2 milligram press tablet

play16:42

instead of a zero instead of a one

play16:44

that's something i'm going to be looking

play16:45

into with my hrt clinic is if

play16:47

if that's even [ __ ] possible and it

play16:49

should be i don't see why it's not but

play16:50

with dutasteride and these soft gels and

play16:52

the avo dark capsules

play16:53

you're looking at 0.5 milligrams like

play16:55

that's what's available there's nothing

play16:56

[ __ ] else available so

play16:58

giving yourself the ability and that's

play17:00

sort of like you know where topical

play17:01

finasteride can be advantageous too like

play17:03

at least

play17:04

at least you have a press tablet though

play17:06

you can manipulate if you're doing

play17:07

orally but even when you start to cut it

play17:08

into quarters

play17:09

the [ __ ] can turn into dust pretty quick

play17:11

and make it kind of problematic

play17:12

like quarters is kind of doable but

play17:16

you know like even for that like some

play17:17

people if you're getting a pro scar

play17:19

tablet for example it's five milligrams

play17:20

you're cutting into 1.25

play17:22

where do you go from there if that's

play17:24

what you have available to you you know

play17:25

it's not like you can cut that into

play17:26

smaller pieces

play17:27

and with you taps right you have no

play17:28

manipulation at all so you know this is

play17:31

where the topical has

play17:32

advantage too because you can literally

play17:34

manipulate the amount

play17:36

and the concentration of the solution

play17:38

based on what you need and not be kind

play17:40

of like subjected to whatever the

play17:42

um pharmaceutical giants have

play17:44

essentially deemed as the dose you need

play17:46

to be taking regardless of what you want

play17:48

or what

play17:49

don't want to do so you know with

play17:50

dutaster you can use as low as

play17:53

[ __ ] whatever you want and you can

play17:55

use it as

play17:56

frequently or and frequently as you want

play17:58

it's like obviously you could use oral

play17:59

do tasks right you know infrequently

play18:01

just like these detached right

play18:02

mesotherapy protocols

play18:04

but you're you can't avoid that like

play18:06

significant

play18:08

[ __ ] crash in dht whereas with the

play18:11

mesotherapy

play18:12

and with the just i don't know topical

play18:14

in general you have

play18:15

you have a choice between what you're

play18:17

applying to your head it's not just like

play18:18

you have to use 0.5 milligrams and

play18:20

that's [ __ ] all you can deal with

play18:22

you have a choice so as far as uh

play18:25

you know it's merit it is promising and

play18:27

i think you know for a lot of people

play18:29

like if you are risk-averse obviously do

play18:32

doing a topical dutasteride experiment

play18:34

before going to oral

play18:36

makes a lot of sense obviously if you

play18:37

were somebody who was going to go down

play18:39

the rabbit hole of dutasteride to begin

play18:41

with

play18:41

you know going the topical route makes a

play18:43

lot of sense in my opinion before

play18:45

jumping like full board into a oral

play18:47

treatment that you know produces these

play18:48

metabolites that are going to linger

play18:50

and the entire compound plus metabolites

play18:54

is going to have a half-life of

play18:56

[ __ ] four to five weeks like

play18:58

once you get on oral dutasteride like

play19:00

you're in it dude you're in it for a

play19:02

while

play19:03

because this [ __ ] lasts so with topical

play19:05

it seems like it doesn't last

play19:06

as long perhaps the metabolite thing you

play19:09

have more manipulation of your dosage

play19:11

you can get to a more micro dose not

play19:12

have to deal with a massive

play19:14

you know dis just [ __ ] nuke your

play19:17

system overnight kind of thing

play19:19

and um you may get a disproportionate

play19:22

decrease in scalp dht relative to serum

play19:24

you know

play19:25

this might be the first off 5ar

play19:27

inhibitor that actually is able to

play19:28

achieve that you know so

play19:30

you know more data needs to come out for

play19:32

us to have any definitive conclusions

play19:34

but for me

play19:35

it's kind of like a no-brainer if you

play19:36

have it available to you to

play19:38

go with that before oral like at least

play19:41

if you were

play19:43

side effect prone or worried about side

play19:45

effects significantly if you don't want

play19:46

to go the full

play19:47

like like dude oral due task right i

play19:50

would consider

play19:50

like part of the most like

play19:54

it's not like nuclear like i always talk

play19:55

about these nuclear options but it's

play19:57

kind of like

play19:57

the most aggressive of dht inhibition

play19:59

you can really do as well as

play20:01

neurosteroid inhibition so it's like

play20:03

some people don't care enough to want to

play20:07

step by step you know put on the

play20:09

training wheels before getting there

play20:10

but then there's some people who want

play20:12

the minimum effective dose

play20:14

with the least side effects which

play20:15

obviously makes the most [ __ ] sense

play20:17

because if you can get

play20:18

hair loss prevention with i don't know

play20:21

like one

play20:22

tenth of the systemic inhibition of dht

play20:24

and

play20:25

potentially neurosteroids then why not

play20:29

then that begs the question though too

play20:30

is if you're applying something right

play20:31

onto your [ __ ] head where your brain

play20:33

is

play20:34

does that have a disproportionate

play20:35

decrease in your neural steroid

play20:37

neurosteroid production

play20:38

you know there's a lot of unanswered

play20:39

questions and

play20:41

a lot of this is kind of just like bro

play20:43

science theory

play20:44

um at the end of the day but it's new

play20:47

new

play20:48

[ __ ] you know we're learning new [ __ ] as

play20:49

we go and this is this is what i've seen

play20:51

to date i think if you're somebody who

play20:53

is looking at dutastride then

play20:54

topical is definitely worth exploring

play20:56

first to you know assess your

play20:59

tolerability of it from a more like

play21:02

micro dose perspective

play21:03

in addition i think some people who

play21:05

don't tolerate finasteride very well

play21:08

um are going to get [ __ ] if they used

play21:11

oral dutasteride obviously so they can't

play21:13

do that like why would you can't go to a

play21:14

more aggressive therapy if

play21:16

you used oral finasteride or topical and

play21:18

had problems with it

play21:19

however i have heard of people using

play21:21

oral finasteride

play21:22

topical finasteride getting sides and

play21:24

then going to a

play21:26

really really like moderate dose of

play21:29

topical dutasteride

play21:31

and having no side effects it's really

play21:33

interesting so you know i think it has a

play21:34

lot of promise for

play21:35

a lot of people potentially you know it

play21:37

may not just be for people who want to

play21:38

go aggressive like everyone thinks oh

play21:40

detaster it's the strongest

play21:42

5ar inhibitor so if if i'm fine with

play21:44

finasteride like why would i even bother

play21:46

or if i don't want to go above the you

play21:48

know intensity of finasteride why would

play21:50

i bother

play21:50

it's like it might have less intensity

play21:52

than finasteride for all we know from a

play21:54

serum

play21:54

dhc inhibition context then again there

play21:57

are

play21:58

you know like token individuals who

play22:00

claim that it's gonna do the exact same

play22:02

thing as finasteride does and eventually

play22:03

it's going to reach

play22:04

enough inhibition systemically to

play22:06

essentially

play22:07

you know do the same [ __ ] that topical

play22:09

uh finasteride does

play22:11

there's not really any data to reinforce

play22:12

anything we just have anecdotal findings

play22:14

and [ __ ] some blood work from

play22:16

a handful of dudes to be honest so for

play22:19

me

play22:20

i take the word of guys that i respect

play22:23

in this community and guys that i uh

play22:26

you know uh defer to on certain things

play22:28

that even i'm less knowledgeable about

play22:31

and some of them i've seen good results

play22:33

so

play22:34

you know for me that's promising enough

play22:36

and the theories i've come up with

play22:38

through the

play22:39

manipulation of five ir on the scalp

play22:41

localized activity you know

play22:42

even talking about like the topical

play22:44

nandrolone in the past

play22:45

disproportionately spiking

play22:46

dihydromandrel in concentration sarms

play22:48

etc

play22:49

all these things have a lot of

play22:51

therapeutic promise and i've seen it

play22:52

play out enough times now to know that

play22:54

there is some [ __ ]

play22:55

that is worth exploring further when it

play22:58

comes to localized concentrations of

play22:59

drugs so

play23:00

for me you know the first pass thing

play23:03

skipping the metabolites as much you

play23:04

know the manipulation of the half-life

play23:06

potentially i'm getting a microdosing

play23:09

that you otherwise wouldn't be able to

play23:10

do

play23:11

um the disproportionate decrease in

play23:14

scalp dht relative to serum like there's

play23:16

so many [ __ ]

play23:18

things that make this so promising that

play23:20

it's just a no-brainer to explore

play23:21

further and

play23:22

for who this is viable for i can't say

play23:25

like you should try this but

play23:27

like you're gonna have to you're gonna

play23:28

have to decide if it's a good uh if

play23:30

you're a viable candidate or not because

play23:32

it's not like

play23:32

anyone it's not like there's any kind of

play23:34

like prescription criteria for this [ __ ]

play23:36

to begin with

play23:36

even oral due taster like i'm pretty

play23:38

sure it's only approved for hair loss in

play23:40

like

play23:40

a handful of countries or some [ __ ] and

play23:42

it's definitely not in north america so

play23:44

yeah dude you know you have to figure it

play23:46

out yourself like i said though

play23:47

at least the one criteria i can say is

play23:50

some guy who is thinking about

play23:51

graduating to do tasteride but is

play23:53

worried about the side effects

play23:55

that individual would be wise to you

play23:58

know explore some of the topical

play24:01

stuff or mesotherapy practices before

play24:04

diving headfirst

play24:05

into a four to five week half-life oral

play24:07

treatment that is going to keep them

play24:10

and their neuro their neurosteroid

play24:12

production and their dht production

play24:14

like really [ __ ] hindered for months

play24:17

on end so

play24:18

anyways that is my stance on i think it

play24:20

has a lot of promise

play24:21

and i think it is uh definitely worth

play24:23

looking at

play24:24

so and again though keep in mind this is

play24:26

not a turnkey solution this is dealing

play24:28

with

play24:28

scalp dht has nothing to do with scalp

play24:31

testosterone has nothing to do with any

play24:33

of the other circulating androgens in

play24:35

your body

play24:36

which there are other ones not just dhc

play24:38

not just dht not just testosterone there

play24:40

are other androgens too

play24:42

the steroidogenesis cascade does not

play24:45

yield

play24:45

just two things that are androgenic and

play24:47

have affinity for ar

play24:49

and have their own inherent binding

play24:50

constant dissociation rates and their

play24:52

own

play24:53

um response elements that they elicit

play24:54

when they bind and activate the ar and

play24:56

do a bunch of [ __ ]

play24:57

this is stuff that has to be accounted

play24:59

for from a more

play25:00

broad spectrum perspective um

play25:04

if you're very prone to hair elastic

play25:06

obviously maybe if you just you know

play25:07

inhibit dht enough yeah sure maybe

play25:09

you'll get through the majority of your

play25:10

life with no issues but at the end of

play25:11

the day

play25:12

when you're using especially if you get

play25:13

this disproportionate decrease in scalp

play25:15

dht

play25:16

do you know what that's gonna lead to

play25:17

too a disproportionate spike in scalp

play25:19

tea

play25:20

like you're gonna get a giant spike in

play25:21

scalp testosterone

play25:23

if we're getting what we're trying to

play25:24

get out of this stuff like if we're

play25:25

succeeding

play25:26

in nuking scalp dht levels 80

play25:30

think of what that's doing to your scalp

play25:31

testosterone all that 5ar

play25:33

where your tea would otherwise be going

play25:35

through the dhc is now left as tea and

play25:37

it's just chilling in your scalp and

play25:38

what do you have to deal with that what

play25:39

do you have to clean that up with

play25:41

well now you're looking at ar inhibitors

play25:43

now you're looking at

play25:44

selective androgen receptor modulators

play25:45

now you're looking at other ar agonists

play25:47

that compete or

play25:48

ar whatever you want to [ __ ] do

play25:50

whatever your mod

play25:52

your preferred modality of dealing with

play25:54

androgen receptor activation and

play25:56

selective androgen receptor degraders

play25:58

you know there's so many [ __ ] things

play25:59

that are worth exploring but in general

play26:02

anti-androgens are going to be the

play26:04

modality that most people

play26:05

would probably you know resort to first

play26:09

as it's the most uh i don't know tried

play26:12

and true

play26:12

most well understood most uh like we

play26:15

actually know what the [ __ ] it's doing

play26:16

we know how to predict exactly what it's

play26:18

going to do to our hormone profile based

play26:20

on if it's a non-steroidal anti-androgen

play26:22

or a steroidal anti-androgen and what

play26:23

kind of downstream

play26:24

effects it may or may not have and there

play26:26

are actual compounds being evaluated in

play26:29

the clinical setting right now that are

play26:30

actually you know designed to deal with

play26:32

this [ __ ] too so obviously

play26:33

that's really promising too so you know

play26:36

the classic kind of uh

play26:38

first line of defense would be you know

play26:40

if you inhibit your scalp dht that much

play26:42

you've dealt with that

play26:43

now we have to deal with broad spectrum

play26:45

ar activation to begin with so now we

play26:47

have you know

play26:48

cb0301 um ru58841

play26:51

florida whatever it is that you choose

play26:52

whatever it is your preferred

play26:54

anti-androgen of choice is

play26:56

based on what you deem cost efficient

play26:59

um most effective least side effect

play27:02

written

play27:03

most clinical data backing its efficacy

play27:05

and safety profile whatever it is that

play27:06

is your criteria for what is the

play27:09

ideal anti-androgen like that would be

play27:11

the next step to deal with it from a

play27:13

broad spectrum perspective but

play27:14

i do believe that that is a very

play27:16

comprehensive protocol and would serve a

play27:18

lot of people to

play27:19

like fully protect them to be honest you

play27:21

have a topical dutastride plus an

play27:23

anti-androgen that would be a very you

play27:24

know thoroughly well thought out

play27:26

protocol in my

play27:27

opinion and then from there if you

play27:28

needed to re-regain ground like i feel

play27:31

like that would be enough to stave off

play27:32

further loss and if you needed to regain

play27:34

ground

play27:36

you know that's where you would

play27:36

intervene with you know microneedling

play27:39

minoxidil whatever it is that you decide

play27:42

is your growth agonist of choice there's

play27:43

other things you can do too obviously

play27:45

that i've discussed on my channel many

play27:46

times but

play27:48

that is the sort of like you know that

play27:50

is how topical dues asteroid would be

play27:51

used

play27:52

in a very broad general way like not

play27:54

actually digging into the dosages not

play27:55

digging into which application

play27:57

technique or vehicle or whatever you

play27:59

should be using because frankly that's a

play28:00

[ __ ] five-hour video

play28:02

probably trying to describe all of the

play28:03

different ways this thing can be

play28:05

leveraged like it's very uh

play28:06

there are a lot of different theories

play28:08

going around right now but at the end of

play28:09

the day like i said

play28:11

it definitely does work like when you

play28:13

actually look at the mesotherapy results

play28:14

they're very good

play28:15

when you look at the topical results

play28:17

they're very good um

play28:18

they're not as good as oral but you

play28:20

would expect as such without as much

play28:22

systemic absorption like you're not

play28:23

getting the [ __ ] 99

play28:25

inhibition you're getting i don't know

play28:27

70 80 scalp inhibition it seems like but

play28:29

that's [ __ ] great you know if you can

play28:31

get away with it side effect free you

play28:32

know that's what some people need

play28:34

so anyways take from that way you will

play28:35

thank you guys for watching please like

play28:36

subscribe check out my blog more

play28:38

placementates.com follow me on instagram

play28:39

and more please underscore more dates

play28:41

facebook snapchat it's your twitter tick

play28:42

tock apple podcasts if you want to

play28:43

support the channel you can check out

play28:44

anything

play28:45

i am associated with in the video

play28:46

description below notably my trt clinic

play28:49

where we have

play28:49

pharma grade hair loss medications and

play28:51

hopefully

play28:53

in the future um i can work with a

play28:55

compounding pharmacy to get

play28:56

topical due tasteride made that would be

play28:58

nice to have uh

play29:00

available domestically in the states i

play29:02

don't know how likely that is to happen

play29:04

but uh that is on my to-do list

play29:06

um other you know mainstream medications

play29:08

that are

play29:09

fda approved or through our clinic as

play29:11

well and as well as my recommended lab

play29:13

test panels you know classic hrt trt

play29:16

getting your health assessed in general

play29:18

you may not need any of this [ __ ] maybe

play29:20

you just want a doctor to actually look

play29:21

at you and make sure you're healthy

play29:22

and everything is firing in all

play29:23

cylinders you don't have any imbalances

play29:25

or deficiencies

play29:26

by all means we do it all you know it's

play29:28

telemedicine from the comfort of your

play29:29

own home

play29:29

skype facetime zoom whatever's

play29:31

convenient for you um

play29:32

it's a way of the future in my opinion

play29:34

it's [ __ ] great anything else i'm

play29:35

associated with gorilla my new tropic

play29:37

formulas gorilla mode pre-workout

play29:38

formulas that design myself from scratch

play29:40

um and anything else i am associated

play29:42

with it's all in the video description

play29:43

below thank you guys for watching

play29:45

talk to you soon

Rate This

5.0 / 5 (0 votes)

Related Tags
Topical DutasterideHair LossSystemic EffectsMesotherapyScalp DHTFinasteride5AR InhibitionTherapeutic PromiseHealthcare AdviceTelemedicine